Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00506415
Status:
COMPLETED
Last Update Posted:
2012-09-19
First Post:
2007-07-20
Brief Title:
Comparative Efficacy Safety and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimers Disease AD Showing Cognitive Decline
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis